Home Infusion Therapy Devices Market

Home Infusion Therapy Devices Market Outlook and Forecast 2025 to 2035

The global home infusion therapy devices market is valued at USD 2.6 billion in 2025 and is poised to reach USD 4.8 billion by 2035, registering a CAGR of 6.4%. This growth is expected to be driven by the rising prevalence of chronic illnesses such as cancer, diabetes, and immune disorders, alongside a strong global push toward home-based healthcare.

Quick Stats of Home Infusion Therapy Devices Market

• Market Value (2025): USD 2.6 billion
• Forecast Value (2035): USD 4.8 billion
• Forecast CAGR: 6.4%
• Product Type Leader in 2025: Disposable Elastomeric Pumps (38% market share)
• Top End-User Segment: Home Care Settings (62% market share)
• Key Growth Country: (Japan is the fastest-growing market with 6.6% CAGR)

Metric	Value
Estimated Market Size (2025)	USD 2.6 Billion
Projected Market Size (2035)	USD 4.8 Billion
CAGR (2025 to 2035)	6.4%

Increased patient preference for comfort, reduced hospital visits, and cost-effective treatment alternatives have been positioning home infusion as a preferred therapeutic pathway in both developed and emerging markets. The shift toward decentralizing healthcare services has been reinforced by advancements in remote monitoring and the integration of telehealth services.

In 2025, the home infusion therapy devices market is expected to be led by disposable elastomeric pumps, which are projected to account for 38% of the total market share by device type, owing to their portability, cost-efficiency, and ease of use in antibiotic and chemotherapy delivery.

Simultaneously, home care settings are anticipated to dominate the end-user segment, capturing approximately 62% of the market share, driven by the growing demand for patient-centric, home-based treatment models. Among the countries analyzed, Japan is forecasted to register the highest CAGR of 6.6% between 2025 and 2035, supported by an aging population, robust investment in digital health infrastructure, and widespread adoption of AI-integrated infusion systems.

Challenges such as high device costs and regulatory hurdles are being addressed through flexible reimbursement models, improved compliance tracking, and the adoption of sustainable product materials. As smart healthcare ecosystems continue to evolve, the home infusion therapy devices market is expected to remain a pivotal segment in modern chronic care delivery.

Innovations in device technology have been prioritized, with manufacturers focusing on programmable infusion systems, IoT-enabled monitoring, and extended battery life. These advancements are being integrated to enhance treatment accuracy, reduce human error, and support remote supervision, enabling caregivers and healthcare providers to ensure safer and more efficient home-based infusion therapy.

Analyzing Home Infusion Therapy Devices Market by Top Investment Segments

The market is segmented into product type, application, end user, and region. By product type, the market is divided into disposable elastomeric pumps, insulin pumps, PCA pumps, electronic ambulatory pumps, and infusion system accessories. Based on application, the market is categorized into enteral nutrition, parenteral nutrition, chemotherapy, antibiotic administration, and others (pain management, hydration therapy, immune globulin therapy, and antiviral treatments).

In terms of end user, the market is segmented into home care settings and long-term care centers. Regionally, the market is classified into North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, and Middle East & Africa.

Disposable Elastomeric Pumps to Lead the Product Type Segment with 38% Market Share

Disposable elastomeric pumps are projected to lead the product type segment, accounting for 38% of the global market share by 2025. Their use has been encouraged by portability, cost-efficiency, and ease of operation in home-based settings for therapies such as antibiotics and chemotherapy.

• A consistent flow rate has been delivered without the need for electronics.
• Patient adherence has been supported through discreet and lightweight designs.
• Basic training needs and lack of external power dependency have simplified usage.
• These pumps have been used across various chronic care treatment protocols.

Home Care Settings to Dominate the End User Segment with 62% Market Share

Home care settings are expected to account for 62% of the total market share in 2025, driven by rising demand for decentralized treatment, reduced hospitalization costs, and growing support for remote patient care models.

• Comfort and autonomy have been offered to patients within home environments.
• Insurance coverage and supportive regulations have enhanced adoption.
• Remote monitoring systems and telemedicine platforms have been integrated.
• The segment has catered to patients with chronic and post-acute care needs.

Enteral Nutrition to Lead the Applications Segment with 34% Market Share

Enteral nutrition is projected to lead the application segment, accounting for 34% of the global market share, due to its applicability in managing long-term nutritional support for patients with gastrointestinal and neurological conditions.

• Use has been observed in home recovery programs, geriatric care routines, and chronic illness management.
• Device compatibility with feeding tubes and flow regulation mechanisms has been enhanced.
• Market demand has been supported by growing awareness around home-based clinical nutrition.

Top Home Infusion Therapy Devices Market Dynamics

The home infusion therapy devices market is being influenced by the growing shift toward home-based chronic care, the integration of smart infusion technologies, and efforts to minimize hospital stays. Demand has been supported by cost-effective treatment options, increased patient comfort, and expansion of digital health infrastructure.

Recent Trends in the Home Infusion Therapy Devices Market

• Smart infusion pumps with real-time monitoring and IoT features have been increasingly adopted.
• Wireless connectivity and cloud-based dosage tracking are being integrated into home-care models.
• Use of biocompatible and recyclable device materials has been encouraged by sustainability goals.
• Portable and battery-efficient infusion systems have been launched for extended in-home usage.

Challenges in the Home Infusion Therapy Devices Market

• High initial costs of advanced infusion devices have been restricting access in low-income settings.
• Compliance with evolving regional regulations (e.g., FDA, CE, ISO) has required significant investment.
• Reimbursement disparities across regions have been limiting device uptake among certain populations.
• User training and safety risks associated with home administration have posed implementation barriers.

Analyzing Top Countries Manufacturing and Supplying Home Infusion Therapy Devices

USA Home Infusion Therapy Devices Market Analysis

The USA home infusion therapy devices market is expected to grow at a CAGR of 6.5% from 2025 to 2035. This expansion is being driven by a rising chronic disease burden, the integration of smart infusion technologies, and supportive reimbursement frameworks that are encouraging home-based treatment.

• Advanced wearable infusion pumps have been adopted for cancer and diabetes care.
• Remote monitoring systems are integrated for real-time patient supervision.
• Favorable insurance policies are increasing device accessibility.
• Telehealth adoption is accelerating home therapy delivery.

Home Infusion Therapy Devices Sales Analysis in the UK

The UK home infusion therapy devices market is projected to grow at a CAGR of 6.3% during the forecast period. Growth has been supported by the shift toward decentralized healthcare, the aging population, and government incentives promoting digital health infrastructure.

• Investment has been directed toward portable IV therapy systems.
• Telemedicine platforms are enabling wider adoption of home infusion.
• Public and private partnerships are funding smart infusion device rollouts.
• Precision drug delivery is being prioritized across care pathways.

Germany Home Infusion Therapy Devices Market Analysis

Germany’s home infusion therapy devices market is forecasted to expand at a CAGR of 6.2% from 2025 to 2035. Growth is being supported by robust healthcare infrastructure, high awareness of patient safety, and the country’s commitment to personalized medicine.

• Home-based biologics administration is gaining traction.
• Infusion systems are aligned with EU regulatory compliance.
• High demand is observed in oncology and metabolic disorder treatment.
• Collaboration between hospitals and homecare providers is strengthening.

Home Infusion Therapy Devices Demand Analysis IN fRANCE

The home infusion therapy devices market in France is anticipated to grow at a CAGR of 6.1% over the forecast period. Emphasis on quality care, environmental sustainability, and integrated treatment planning is encouraging adoption of home infusion systems, especially in long-term care and post-acute recovery.

• Biocompatible and eco-friendly device materials are under development.
• Healthcare professionals are being trained in home-based infusion protocols.
• Demand for automated drug delivery systems is expanding.
• Hybrid care models are being implemented for chronic disease management.

Japan Home Infusion Therapy Devices Market Analysis

Japan’s home infusion therapy devices market is projected to grow at a CAGR of 6.6% through 2035. With a rapidly aging population and advancements in medical technology, the country continues to prioritize home-based chronic care using precision-engineered, smart infusion systems.

• AI-powered infusion pumps are being integrated for complex therapies.
• Remote health platforms are supporting continuous monitoring.
• Demand has risen from geriatric and cancer care segments.
• Regulatory initiatives are promoting safer and more connected devices.

Leading Home Infusion Therapy Devices Suppliers and Distributors

The home infusion therapy devices market is considered moderately consolidated, with several international companies accounting for significant market shares, while regional manufacturers and niche technology players continue to introduce specialized solutions. Competitive positioning has been shaped by advancements in device connectivity, strategic collaborations with homecare providers, and expansion into emerging healthcare markets.

Tier-one firms such as Becton, Dickinson and Company (BD), Baxter International Inc., Fresenius Kabi AG, ICU Medical, Inc., and Smiths Medical have been focusing on smart infusion solutions, wireless integration, and ergonomic design improvements. These companies have invested in AI-enabled drug delivery systems, expanded their product portfolios through acquisitions, and partnered with telehealth providers to support remote monitoring and personalized infusion therapy.

Recent Home Infusion Therapy Devices Industry News

• In January 2025, Johnson & Johnson signed a definite agreement with Intra-Cellular Therapies, Inc. to boost its product portfolio.
• In June 2025, Nipro concluded a strategic partnership agreement with Samsung Bioepis for the commercialization of biosimilars in Japan.

Home Infusion Therapy Devices Market Report Scope

Report Attributes	Details
Current Total Market Size (2025)	USD 2.6 billion
Projected Market Size (2035)	USD 4.8 billion
CAGR (2025 to 2035)	6.4%
Base Year for Estimation	2024
Historical Period	2020 to 2024
Projections Period	2025 to 2035
Market Analysis Parameters	Revenue in USD billions / Volume in units
By Device Type	Disposable Elastomeric Pumps, Insulin Pumps, PCA Pumps, Electronic Ambulatory Pumps, Infusion System Accessories
By Application	Enteral Nutrition, Parenteral Nutrition, Chemotherapy, Antibiotic Administration, Others (Pain Management, Hydration Therapy, Immune Globulin Therapy, Antiviral Treatments)
By End User	Home Care Settings, Long-Term Care Centers
Regions Covered	North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, Middle East & Africa
Countries Covered	United States, Canada, United Kingdom, Germany, France, Japan, South Korea, China, India, Australia
Key Players	Becton, Dickinson and Company (BD), Baxter International Inc., Fresenius Kabi AG, ICU Medical, Inc., Smiths Medical, Nipro Corporation, Johnson & Johnson, F. Hoffmann-La Roche Ltd, Pfizer Inc., Terumo Corporation
Additional Attributes	Dollar sales by value, market share analysis by region, and country-wise analysis

Home Infusion Therapy Devices Market Segmentation

By Product Type:

• Disposable Elastomeric Pumps
• Insulin Pumps
• PCA Pumps
• Electronic Ambulatory Pumps
• Infusion System Accessories

By Applications:

• Enteral Nutrition
• Parenteral Nutrition
• Chemotherapy
• Antibiotic Administration
• Others

By End User:

• Home Care Settings
• Long-Term Care Centers

By Region:

• North America
• Latin America
• East Asia
• South Asia & Pacific
• Eastern Europe
• Western Europe
• Middle East & Africa